Impact of Interval Debulking Surgery on Clinical Outcome in Primary Unresectable FIGO Stage IIIc Ovarian Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|65|4|316-322

ISSN： 0030-2414

Source： Oncology, Vol.65, Iss.4, 2004-01, pp. : 316-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interval Debulking Surgery in Patients with Federation of Gynecology and Obstetrics (FIGO) Stage IIIC and IV Ovarian Cancer

By  

Oncology Research and Treatment, Vol. 36, Iss. 6, 2013-05 ,pp. : 324-332

Karger

Access to resources Recommend Favorite

Does the Number of Neoadjuvant Chemotherapy Cycles before Interval Debulking Surgery Influence Survival in Advanced Ovarian Cancer?

By  

Oncology, Vol. 91, Iss. 6, 2016-10 ,pp. : 331-340

Karger

Access to resources Recommend Favorite

Clinical Outcome of a FIGO Stage IV Gestational Choriocarcinoma

By  

Case Reports in Oncology, Vol. 6, Iss. 3, 2013-09 ,pp. : 504-507

Karger

Access to resources Recommend Favorite

Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer

By  

Current Women's Health Reviews, Vol. 5, Iss. 1, 2009-02 ,pp. : 44-50

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical impact of selective and nonselective beta‐blockers on survival in patients with ovarian cancer

By  

CANCER, Vol. 121, Iss. 19, 2015-10 ,pp. : 3444-3451

John Wiley & Sons Inc

Access to resources Recommend Favorite